WHO Commissions Global Commitment to Eliminate Cervical Cancer

The World Health Organization, WHO, on Tuesday commissioned the global strategy to accelerate the elimination of cervical cancer globally.

WHO, while outlining the three key steps to achieving the goal – vaccination, screening and treatment, noted that successful implementation of all three could reduce more than 40 percent of new cases of the disease and 5 million related deaths by 2050.

According to the WHO Director-General, Dr Tedros Adhanom Ghebreyesus, “Eliminating any cancer would have once seemed an impossible dream, but we now have the cost-effective, evidence-based tools to make that dream a reality.

“But we can only eliminate cervical cancer as a public health problem if we match the power of the tools we have with unrelenting determination to scale up their use globally.”

The WHO Assistant Director-General, Dr Princess Nothemba (Nono) Simelela, added, “The huge burden of mortality related to cervical cancer is a consequence of decades of neglect by the global health community. However, the script can be rewritten.

“Critical developments include the availability of prophylactic vaccines; low-cost approaches to screening and treating cervical cancer precursors; and novel approaches to surgical training. Through a shared global commitment to the Sustainable Development Goals and leaving no-one behind, the countries of the world are forging a new path to ending cervical cancer.

“The fight against cervical cancer is also a fight for women’s rights: the unnecessary suffering caused by this preventable disease reflects the injustices that uniquely affect women’s health around the world. Together, we can make history to ensure a cervical cancer-free future.”

The development represents a historic milestone because it marks the first time that 194 countries commit to eliminating cancer – following adoption of a resolution at this year’s World Health Assembly.

Meeting the above targets by 2030 will ensure that 90 percent of girls fully vaccinated with the HPV vaccine by 15 years of age, 70 percent of women are screened using a high-performance test by age 35 and again by 45, and 90 percent of women identified with cervical disease receive treatment (90 percent of women with pre-cancer treated and 90 percent of women with invasive cancer managed).

The strategy also stressed that investing in the interventions to meet these targets can generate substantial economic and societal returns. An estimated US$ 3.20 will be returned to the economy for every dollar invested through 2050 and beyond, owing to increases in women’s workforce participation. The figure rises to US$ 26.00 when the benefits of women’s improved health on families, communities and societies are considered.

Enjoyed this article? Stay informed by joining our newsletter!


You must be logged in to post a comment.

About Author